The Human Upgrade: Biohacking for Longevity & Performance

Digital Twins: The End of Human Drug Testing for Biohackers : 1342

103 snips
Oct 9, 2025
In this enlightening discussion, Dr. Derya Unutmaz, a world-renowned immunologist at The Jackson Laboratory, shares insights on how AI-powered digital twins can revolutionize drug discovery and potentially eliminate human trials. He highlights the promise of personalized medicine tailored to individual biology for longevity and health. Derya also discusses the role of AGI in transforming medical practice, the need for a re-engineered immune system, and practical strategies for using compounds like metformin and GLP-1 to enhance lifespan.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Digital Twins Shrink Drug Timelines

  • AI can simulate virtual cells, tissues, and digital twins to run biological experiments in minutes instead of years.
  • This capability could collapse drug development timelines and transform personalized medicine.
ADVICE

Personalize Medicine With Digital Twins

  • Personalization must replace one-size-fits-all medicine by using digital twins to run individualized drug tests.
  • Regulators will need to adapt because demand for personalized, faster trials will drive change.
INSIGHT

Immune System Is A Legacy Problem

  • The immune system is a legacy, layered system that causes many chronic diseases via overreaction and misregulation.
  • Re-engineering immunity into an 'immune system 2.0' could reduce inflammation-driven aging and disease.
Get the Snipd Podcast app to discover more snips from this episode
Get the app